Business Description
Gennbio Inc
ISIN : KR7072520000
Compare
Compare
Traded in other countries / regions
072520.Korea IPO Date
2004-10-29Description
Gennbio Inc builds drug and bio long-term development platform. The company produces models of primate diseases such as organ transplants and immune or diabetic models.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | N/A |
N/A
|
N/A
| |||
| Equity-to-Asset | 0.58 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | -0.33 | |||||
| Beneish M-Score | -2.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -28.5 | |||||
| 3-Year EBITDA Growth Rate | 36.9 | |||||
| 3-Year EPS without NRI Growth Rate | 34.6 | |||||
| 3-Year FCF Growth Rate | 19.9 | |||||
| 3-Year Book Growth Rate | 10.7 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 16.86 | |||||
| 9-Day RSI | 21.81 | |||||
| 14-Day RSI | 25.93 | |||||
| 6-1 Month Momentum % | -66.48 | |||||
| 12-1 Month Momentum % | -59.52 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.61 | |||||
| Quick Ratio | 0.61 | |||||
| Days Inventory | 8.07 | |||||
| Days Sales Outstanding | 212.4 | |||||
| Days Payable | 37.02 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -23.4 | |||||
| Shareholder Yield % | -73.32 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 17.01 | |||||
| Operating Margin % | -124.87 | |||||
| Net Margin % | -412.89 | |||||
| ROE % | -50.29 | |||||
| ROA % | -27.37 | |||||
| ROIC % | -7.24 | |||||
| ROC (Joel Greenblatt) % | -15.19 | |||||
| ROCE % | -16.04 |
GF Value Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 2.15 | |||||
| PB Ratio | 0.34 | |||||
| Price-to-Tangible-Book | 0.31 | |||||
| EV-to-EBIT | -4.27 | |||||
| EV-to-EBITDA | -5.15 | |||||
| EV-to-Revenue | 7.19 | |||||
| EV-to-FCF | -1.64 | |||||
| Price-to-Median-PS-Value | 0.6 | |||||
| Earnings Yield (Greenblatt) % | -23.4 |
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gennbio Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil â‚©) | 9,275.218 | ||
| EPS (TTM) (â‚©) | -859.754 | ||
| Beta | 1.07 | ||
| Volatility % | 59.45 | ||
| 14-Day RSI | 25.93 | ||
| 14-Day ATR (â‚©) | 38.080451 | ||
| 20-Day SMA (â‚©) | 492.65 | ||
| 12-1 Month Momentum % | -59.52 | ||
| 52-Week Range (â‚©) | 398 - 3080 | ||
| Shares Outstanding (Mil) | 57.14 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gennbio Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gennbio Inc Stock Events
| Event | Date | Price(â‚©) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gennbio Inc Frequently Asked Questions
What is Gennbio Inc(XKRX:072520)'s stock price today?
The current price of XKRX:072520 is â‚©410.00. The 52 week high of XKRX:072520 is â‚©3080.00 and 52 week low is â‚©398.00.
When is next earnings date of Gennbio Inc(XKRX:072520)?
The next earnings date of Gennbio Inc(XKRX:072520) is .
Does Gennbio Inc(XKRX:072520) pay dividends? If so, how much?
Gennbio Inc(XKRX:072520) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers